REVIEW

The Metabolism of Polyunsaturated Fatty Acids and Its Regulation to Inflammation

  • GONG Jian ,
  • XIAO Min
Expand
  • College of Life Science and Technology, Inner Mongolia Normal University, Huhhot 010022, China

Received date: 2016-07-14

  Online published: 2017-01-16

Abstract

Inflammation is part of protective response to infection or tissue injury. Appropriate or controlled inflammation is necessary to eliminate invading pathogens and repair damaged tissue. However, excessive or uncontrolled inflammation contributes to a range of pathological inflammatory responses, which may result in the increased incidence of both metabolic and infectious diseases. Lipid mediators derived from polyunsaturated fatty acids have important roles in regulating the initiation, development and resolving of inflammatory responses. A better understanding of the metabolism of polyunsaturated fatty acids and its regulation to inflammation will facilitate the development of dietary nutritional strategies to control the incidence of diseases and improve human and animal health. Therefore, the metabolic pathways of polyunsaturated fatty acids and the regulatory mechanism of its metabolic products to inflammation were reviewed in this paper.

Cite this article

GONG Jian , XIAO Min . The Metabolism of Polyunsaturated Fatty Acids and Its Regulation to Inflammation[J]. Chinese Journal of Animal Nutrition, 2017 , 29(1) : 1 -7 . DOI: 10.3969/j.issn.1006-267x.2017.01.001

References

[1] SIMONS K,TOOMRE D.Lipid rafts and signal transduction[J].Nature Reviews Molecular Cell Biology,2000,1(1):31-39.  
[2] STILLWELL W,WASSALL S R.Docosahexaenoic acid:membrane properties of a unique fatty acid[J].Chemistry and Physics of Lipids,2003,126(1):1-27.  
[3] DUMLAO D S,BUCZYNSKI M W,NORRIS P C,et al.High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2011,1811(11):724-736.  
[4] POULSEN R C,GOTLINGER K H,SERHAN C N,et al.Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake[J].American Journal of Hematology,2008,83(6):437-445.  
[5] CALDER P C.Polyunsaturated fatty acids and inflammation[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2006,75(3):197-202.  
[6] CALDER P C.n-3 polyunsaturated fatty acids,inflammation,and inflammatory diseases[J].World Review of Nutrition and Dietetics,2006,83(6):S1505-1519S.
[7] KUHN H,BANTHIYA S,VAN LEYEN K.Mammalian lipoxygenases and their biological relevance[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2015,1851(4):308-330.  
[8] ASTUDILLO A M,BALGOMA D,BALBOA M A,et al.Dynamics of arachidonic acid mobilization by inflammatory cells[J].Biochimica et Biophysica Acta:Molecular and Cell Biology of Lipids,2012,1821(2):249-256.  
[9] MILNE G L,YIN H Y,HARDY K D,et al.Isoprostane generation and function[J].Chemical Reviews,2011,111(10):5973-5996.  
[10] BOUTET P,BUREAU F,DEGAND G,et al.Imbalance between lipoxin A4 and leukotriene B4 in chronic mastitis-affected cows[J].Journal of Dairy Science,2003,86(11):3430-3439.  
[11] MAVANGIRA V,GANDY J C,ZHANG C,et al.Polyunsaturated fatty acids influence differential biosynthesis of oxylipids and other lipid mediators during bovine coliform mastitis[J].Journal of Dairy Science,2015,98(9):6202-6215.  
[12] RYMAN V E,PIGHETTI G M,LIPPOLIS J D,et al.Quantification of bovine oxylipids during intramammary Streptococcus uberis infection[J].Prostaglandins & Other Lipid Mediators,2015,121:207-217.
[13] BAGGA D,WANG L,FARIAS-EISNER R,et al.Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion[J].Proceedings of the National Academy of Sciences of the United States of America,2003,100(4):1751-1756.  
[14] SERHAN C N,CHIANG N.Endogenous pro-resolving and anti-inflammatory lipid mediators:a new pharmacologic genus[J].British Journal of Pharmacology,2008,153(Suppl.1):S200-S215.
[15] SORDILLO L M.Nutritional strategies to optimize dairy cattle immunity[J].Journal of Dairy Science,2016,99(6):4967-4982.  
[16] PATTANAIK U,PRASAD K.Oxygen free radicals and endotoxic shock:effect of flaxseed[J].Journal of Cardiovascular Pharmacology and Therapeutics,1998,3(4):305-318.  
[17] SERHAN C N.Systems approach to inflammation resolution:Identification of novel anti-inflammatory and pro-resolving mediators[J].Journal of Thrombosis and Haemostasis,2009,7:44-48.
[18] CHINTHAMANI S,ODUSANWO O,MONDAL N,et al.Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium[J].American Journal of Physiology:Cell Physiology,2012,302(7):C968-C978.
[19] ALTMANN R,HAUSMANN M,SPÖTTL T,et al.13-Oxo-ODE is an endogenous ligand for PPARγ in human colonic epithelial cells[J].Biochemical Pharmacology,2007,74(4):612-622.  
[20] NATARAJAN R,REDDY M A,MALIK K U,et al.Signaling mechanisms of nuclear factor-κB-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2001,21(9):1408-1413.  
[21] BONOMINI F,TENGATTINI S,FABIANO A,et al.Atherosclerosis and oxidative stress[J].Histology and Histopathology,2008,23(3):381-390.
[22] RAMSDEN C E,RINGEL A,FELDSTEIN A E,et al.Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans[J].Prostaglandins,Leukotrienes and Essential Fatty Acids,2012,87(4/5):135-141.
[23] QUEHENBERGER O,ARMANDO A M,BROWN A H,et al.Lipidomics reveals a remarkable diversity of lipids in human plasma[J].The Journal of Lipid Research,2010,51(11):3299-3305.  
[24] SERHAN C N,CLISH C B,BRANNON J,et al.Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing[J].The Journal of Experimental Medicine,2000,192(8):1197-1204.  
[25] SERHAN C N,HONG S,GRONERT K,et al.A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals[J].The Journal of Experimental Medicine,2002,196(8):1025-1037.  
[26] SERHAN C N,YANG R,MARTINOD K,et al.Maresins:novel macrophage mediators with potent antiinflammatory and proresolving actions[J].The Journal of Experimental Medicine,2009,206(1):15-23.  
[27] LEE T H,MENCIA-HUERTA J M,SHIH C,et al.Effects of exogenous arachidonic,eicosapentaenoic,and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils[J].Journal of Clinical Investigation,1984,74(6):1922-1933.  
[28] SCHWAB J M,CHIANG N,ARITA M,et al.Resolvin E1 and protectin D1 activate inflammation-resolution programmes[J].Nature,2007,447(7146):869-874.  
[29] HASTURK H,KANTARCI A,GOGUET-SURMENIAN E,et al.Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo[J].The Journal of Immunology,2007,179(10):7021-7029.  
[30] TJONAHEN E,OH S F,SIEGELMAN J,et al.Resolvin E2:identification and anti-inflammatory actions:pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis[J].Chemistry & Biology,2006,13(11):1193-1202.  
[31] EICKMEIER O,SEKI H,HAWORTH O,et al.Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury[J].Mucosal Immunology,2013,6(2):256-266.  
[32] DONG J J,LIAO Z L,WANG T,et al.Resolvin-D1 inhibits interleukin-8 and hydrogen peroxide production induced by cigarette smoke extract in 16HBE cells via attenuating NF-κB activation[J].Chinese Medical Journal,2014,127(3):511-517.
[33] BOHR S,PATEL S J,SARIN D,et al.Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model[J].Wound Repair and Regeneration,2013,21(1):35-43.  
[34] DEMARQUOY J,BORGNE F L.Biosynthesis, metabolism and function of protectins and resolvins[J].Clinical Lipidology,2014,9(6):683-693.  
[35] ARIEL A,SERHAN C N.New lives given by cell death:macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation[J].Frontiers in Immunology,2012,3:4.
[36] DALLI J,SERHAN C N.Specific lipid mediator signatures of human phagocytes:microparticles stimulate macrophage efferocytosis and pro-resolving mediators[J].Blood,2012,120(15):e60-e72.
[37] NORDGREN T M,BAUER C D,HEIRES A J,et al.Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust[J].Translational Research,2015,166(1):57-69.  
[38] GONG J,WU Z Y,QI H,et al.Maresin 1 mitigates LPS-induced acute lung injury in mice[J].British Journal of Pharmacology,2014,171(14):3539-3550.  
[39] DALLI J,ZHU M,VLASENKO N A,et al.The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1(MaR1),inhibits leukotriene A4 hydrolase (LTA4H),and shifts macrophage phenotype[J].The FASEB Journal,2013,27(7):2573-2583.  
[40] MARCON R,BENTO A F,DUTRA R C,et al.Maresin 1,a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids,exerts protective actions in murine models of colitis[J].The Journal of Immunology,2013,191(8):4288-4298.  
Outlines

/